deferasirox has been researched along with eicosapentaenoic acid in 2 studies
Studies (deferasirox) | Trials (deferasirox) | Recent Studies (post-2010) (deferasirox) | Studies (eicosapentaenoic acid) | Trials (eicosapentaenoic acid) | Recent Studies (post-2010) (eicosapentaenoic acid) |
---|---|---|---|---|---|
832 | 136 | 572 | 7,171 | 1,304 | 3,623 |
Protein | Taxonomy | deferasirox (IC50) | eicosapentaenoic acid (IC50) |
---|---|---|---|
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | Homo sapiens (human) | 4 | |
Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 7.1 | |
Oxoeicosanoid receptor 1 | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Hussar, DA | 1 |
2 other study(ies) available for deferasirox and eicosapentaenoic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
New drugs 06, part II.
Topics: Analgesics; Benzeneacetamides; Benzoates; Bone Density Conservation Agents; Deferasirox; Diphosphonates; Docosahexaenoic Acids; Drug Approval; Drug Combinations; Drug Interactions; Drug Monitoring; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Eicosapentaenoic Acid; gamma-Aminobutyric Acid; Humans; Ibandronic Acid; Iloprost; Indenes; Minocycline; Patient Education as Topic; Phenylacetates; Pregabalin; Tigecycline; Triazoles; Vasodilator Agents | 2006 |